Status:
COMPLETED
Study to Test the Usability of a New Injector to Administer Contrast Media Into Humans for Diagnostic Purposes
Lead Sponsor:
Bayer
Conditions:
Computed Tomography
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study investigates if a new medical device, which injects contrast media and flushing solution into humans to increase the visibility of images taken of the human body for diagnostic purposes, is...
Detailed Description
The study compares an investigational injection system (Centargo) for computed tomography (CT) to a currently marketed injection system (Stellant MP) in terms of efficiency, cost, performance and user...
Eligibility Criteria
Inclusion
- Adult subjects referred for contrast-enhanced computer tomography using a power injector
Exclusion
- Pregnant and lactating women
- Subjects with know hypersensitivity to iodinated contrast media
- Subjects with unacceptable renal function per local guidelines
Key Trial Info
Start Date :
June 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2020
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT03875469
Start Date
June 21 2019
End Date
March 10 2020
Last Update
March 3 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Medscan
Merrylands, New South Wales, Australia, 2160
2
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6229